Market Tracker

06/24 5:16pm ET

Emergent BioSolutions Inc (NYSE:EBS)

29.34
Delayed Data
As of Jun 24
 -1.31 / -4.27%
Today’s Change
27.68
Today|||52-Week Range
44.38
-26.67%
Year-to-Date
Why Emergent BioSolutions Inc. Procured a Lower Price Today
Jun 22 / MotleyFool.com - Paid Partner Content
Emergent (EBS) BioThrax sBLA Accepted for FDA Review
Jun 20 / Zacks.com - Paid Partner Content
Why is Emergent BioSolutions Inc. (EBS) Down 22% Today?
Jun 22 / Zacks.com - Paid Partner Content
Emergent (EBS) BioThrax Gets Orphan Status in the U.S.
Jun 16 / Zacks.com - Paid Partner Content
Emergent BioSolutions (EBS) Highlighted As Weak On High Volume
Jun 22 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close30.65
Today’s open29.19
Day’s range29.19 - 29.98
Volume1,925,340
Average volume (3 months)448,745
Market cap$1.6B
Dividend yield--
Data as of 4:04pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)+60.23%
Earnings growth (this year)-17.38%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)+16.14%
P/E ratio16.6
Price/Sales3.62
Price/Book2.35

Competitors

 Today’s
change
Today’s
% change
HCMHutchison China Medi...-0.59-4.28%
ITCIIntra-Cellular Thera...-1.36-3.60%
TXMDTherapeuticsMD Inc-0.53-5.99%
PRTAProthena Corporation...-5.07-12.50%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$522.8M
Annual profit (last year)$62.9M
Net profit margin12.03%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel J. Abdun-Nabi
CFO, Treasurer &
Executive VP-Corporate Services
Robert G. Kramer
Corporate headquarters
Gaithersburg, Maryland

Forecasts